1 Min Read
Nov 7 (Reuters) - Fate Therapeutics Inc
* Fate Therapeutics reports third quarter 2016 financial results
* Q3 revenue $1.0 million versus I/B/E/S view $951,000 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.